SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-113453
Filing Date
2019-04-22
Accepted
2019-04-22 16:35:32
Documents
4
Period of Report
2019-04-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d729701d8k.htm 8-K 17949
2 EX-1.1 d729701dex11.htm EX-1.1 205338
3 EX-5.1 d729701dex51.htm EX-5.1 7366
4 GRAPHIC g729701g0420091919579.jpg GRAPHIC 2534
  Complete submission text file 0001193125-19-113453.txt   235449
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36183 | Film No.: 19759752
SIC: 2836 Biological Products, (No Diagnostic Substances)